摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ISPI 55 | 162359-72-0

中文名称
——
中文别名
——
英文名称
ISPI 55
英文别名
2-amino-2-tetradecanyl-1,3-propanediol;2-amino-2-tetradecylpropane-1,3-diol;2-tetradecyl-2-aminopropane-1,3-diol;SSS 943;2-amino-2-tetradecyl-1,3-propanediol
ISPI 55化学式
CAS
162359-72-0
化学式
C17H37NO2
mdl
——
分子量
287.486
InChiKey
BXIWYZLGTUWLCD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5
  • 重原子数:
    20
  • 可旋转键数:
    15
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    66.5
  • 氢给体数:
    3
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    ISPI 55吡啶盐酸三甲基氯硅烷二乙基异丙基胺三氟化硼乙醚 、 sodium hydride 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 生成 Hexadecanoic acid [1-benzyloxymethyl-1-((2S,3S,4S,5R,6R)-3,4,5-tris-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-2-yloxymethyl)-pentadecyl]-amide
    参考文献:
    名称:
    Induction of promotive rather than suppressive immune responses from a novel NKT cell repertoire Vα19 NKT cell with α-mannosyl ceramide analogues consisting of the immunosuppressant ISP-I as the sphingosine unit
    摘要:
    A 2-substituted 2-aminopropane-1,3-diol or 2-aminoethanol is the minimum structure required for the immunosuppressive activity of ISP-I, an antibiotic isolated from the culture broth of Isaria sinclairil. A series of alpha-mannosyl ceramide (alpha-ManCer) analogues was derived from 2-substituted 2-aminopropane-1,3-diols or 2-aminoethanols in place of sphingosine. The newly synthesized glycosides were evaluated for their effects on immune responses. In contrast to the immunosuppressive activity of the precursors, the a-ManCer analogues induced immunopromotive responses from invariant V alpha N-J alpha 26 transgenic mouse lymphocytes more effectively than the original a-ManCer. Collectively, it is strongly suggested that the 2-substituted 2-aminopropane-1,3-diols and 2-aminoethanols mimic sphingosine in the alpha-ManCer analogues so that they potentially acquire specific antigenicity toward V alpha 19 NKT cell, a novel NKT cell subset. (c) 2006 Elsevier SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2005.11.013
  • 作为产物:
    描述:
    溴代十四烷 在 lithium aluminium tetrahydride 、 sodium ethanolate 作用下, 以 四氢呋喃乙醇 为溶剂, 反应 15.5h, 生成 ISPI 55
    参考文献:
    名称:
    Potent Immunosuppressants, 2-Alkyl-2-aminopropane-1,3-diols
    摘要:
    Several immunosuppressants, ISP-I [(2S,3R,4R)-(E)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoeicos-6-enoic acid, myriocin = thermozymocidin] and mycestericins A-G, were isolated from culture broths of Isaria sinclairii and Mycelia sterilia, respectively. In order to investigate structure-activity relationships, extensive modifications of ISP-I were conducted, and it was established that the fundamental structure possessing the immunosuppressive activity is a symmetrical 2-alkyl-2-aminopropane-1,3-diol. The tetradecyl, pentadecyl, and hexadecyl derivatives prolonged rat skin allograft, survival in the combination of LEW donor and F344 recipient and were more effective than cyclosporin A. Among them, 2-amino-2-tetradecylpropane-1,3-diol hydrochloride, ISP-I-55, showed the lowest toxicity. ISP-I-55 is a promising lead compound for the development of effective immunosuppressants for organ transplantations and for the treatment of autoimmune diseases.
    DOI:
    10.1021/jm960391l
点击查看最新优质反应信息

文献信息

  • [EN] NEW LIGANDS FOR TARGETING OF S1P RECEPTORS FOR IN VIVO IMAGING AND TREATMENT OF DISEASES<br/>[FR] NOUVEAUX LIGANDS POUR LE CIBLAGE DE RÉCEPTEURS DE S1P, UTILISÉS DANS L'IMAGERIE IN VIVO ET LE TRAITEMENT DE MALADIES
    申请人:UNIV MUENSTER WILHELMS
    公开号:WO2013026765A1
    公开(公告)日:2013-02-28
    The present invention relates to novel compounds of formulae (I) and (II) which are useful in the prevention, treatment and diagnosis, in vivo diagnosis of diseases or disorders related to S1P receptors, in particular, in diseases which are connected to the regulatory function of sphingosine-1-phosphate (S1P) and its analogues, such as inflammation, pain, autoimmune diseases and cardiovascular diseases.
    本发明涉及具有以下式(I)和(II)的新化合物,其在与S1P受体相关的疾病或紊乱的预防、治疗和体内诊断方面具有用途,特别是在与神经酰胺-1-磷酸鞘氨醇(S1P)及其类似物的调节功能相关的疾病中,如炎症、疼痛、自身免疫疾病和心血管疾病。
  • NEW LIGANDS FOR TARGETING OF S1P RECEPTORS FOR IN VIVO IMAGING AND TREATMENT OF DISEASES
    申请人:Haufe Guenter
    公开号:US20140170067A1
    公开(公告)日:2014-06-19
    The present invention relates to novel compounds of formulae (I) and (II) which are useful in the prevention, treatment and diagnosis, in vivo diagnosis of diseases or disorders related to S1P receptors, in particular, in diseases which are connected to the regulatory function of sphingosine-1-phosphate (S1P) and its analogues, such as inflammation, pain, autoimmune diseases and cardiovascular diseases.
    本发明涉及具有以下化学式(I)和(II)的新化合物,其在预防、治疗和诊断与S1P受体相关的疾病或疾病的体内诊断中有用,特别是在与鞘氨醇-1-磷酸酯(S1P)及其类似物的调节功能相关的疾病中,如炎症、疼痛、自身免疫疾病和心血管疾病。
  • [EN] PHOSPHINANE COMPOUNDS WITH IMMUNOMODULATING ACTIVITY<br/>[FR] COMPOSES DE PHOSPHINANE A EFFET IMMUNOMODULATEUR
    申请人:MITSUBISHI PHARMA CORP
    公开号:WO2005014603A1
    公开(公告)日:2005-02-17
    The invention is directed to a phosphinane compound having a unique immunomodulating activity, a process for a preparation thereof, a pharmaceutical composition containing the same, and a method of preventing or treating disorders or diseases mediated by T lymphocytes by administering the compound to a subject in need of treatment.
    这项发明涉及一种具有独特免疫调节活性的膦环化合物,其制备方法,含有该化合物的药物组合物,以及通过向需要治疗的受试者施用该化合物来预防或治疗由T淋巴细胞介导的疾病或疾病的方法。
  • 2-Amino-propanol derivatives
    申请人:——
    公开号:US20040147490A1
    公开(公告)日:2004-07-29
    Compounds of formula (i), wherein m, R, R 1 , and R 3 to R 6 are as defined in the specification, m, is 1, 2 or 3 and X is O or a direct bond, and the corresponding unphosporylated compounds have interesting properties, e.g. immunosuppressive properties. 1
    式子为(i)的化合物,其中m,R,R1和R3到R6如规范所定义,m为1,2或3,X为O或直接键,并且相应的未磷酸化化合物具有有趣的性质,例如免疫抑制性质。
  • NITRATED HYDROCARBONS, DERIVATIVES, AND PROCESSES FOR THEIR MANUFACTURE
    申请人:ANGUS Chemical Company
    公开号:US20160039843A1
    公开(公告)日:2016-02-11
    Provided is a process for the formation of nitrated compounds by the nitration of hydrocarbon compounds with dilute nitric acid. Also provided are processes for preparing industrially useful downstream derivatives of the nitrated compounds, as well as novel nitrated compounds and derivatives, and methods of using the derivatives in various applications.
    提供了一种通过使用稀硝酸对碳氢化合物进行硝化形成硝基化合物的过程。还提供了制备硝基化合物的工业上有用的下游衍生物的过程,以及新颖的硝基化合物和衍生物,以及在各种应用中使用衍生物的方法。
查看更多

同类化合物

(N-(2-甲基丙-2-烯-1-基)乙烷-1,2-二胺) (4-(苄氧基)-2-(哌啶-1-基)吡啶咪丁-5-基)硼酸 (11-巯基十一烷基)-,,-三甲基溴化铵 鼠立死 鹿花菌素 鲸蜡醇硫酸酯DEA盐 鲸蜡硬脂基二甲基氯化铵 鲸蜡基胺氢氟酸盐 鲸蜡基二甲胺盐酸盐 高苯丙氨醇 高箱鲀毒素 高氯酸5-(二甲氨基)-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-2-甲基吡啶正离子 高氯酸2-氯-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-6-甲基吡啶正离子 高氯酸2-(丙烯酰基氧基)-N,N,N-三甲基乙铵 马诺地尔 马来酸氢十八烷酯 马来酸噻吗洛尔EP杂质C 马来酸噻吗洛尔 马来酸倍他司汀 顺式环己烷-1,3-二胺盐酸盐 顺式氯化锆二乙腈 顺式吡咯烷-3,4-二醇盐酸盐 顺式双(3-甲氧基丙腈)二氯铂(II) 顺式3,4-二氟吡咯烷盐酸盐 顺式1-甲基环丙烷1,2-二腈 顺式-二氯-反式-二乙酸-氨-环己胺合铂 顺式-二抗坏血酸(外消旋-1,2-二氨基环己烷)铂(II)水合物 顺式-N,2-二甲基环己胺 顺式-4-甲氧基-环己胺盐酸盐 顺式-4-环己烯-1.2-二胺 顺式-4-氨基-2,2,2-三氟乙酸环己酯 顺式-2-甲基环己胺 顺式-2-(苯基氨基)环己醇 顺式-2-(氨基甲基)-1-苯基环丙烷羧酸盐酸盐 顺式-1,3-二氨基环戊烷 顺式-1,2-环戊烷二胺 顺式-1,2-环丁腈 顺式-1,2-双氨甲基环己烷 顺式--N,N'-二甲基-1,2-环己二胺 顺式-(R,S)-1,2-二氨基环己烷铂硫酸盐 顺式-(2-氨基-环戊基)-甲醇 顺-2-戊烯腈 顺-1,3-环己烷二胺 顺-1,3-双(氨甲基)环己烷 顺,顺-丙二腈 非那唑啉 靛酚钠盐 靛酚 霜霉威盐酸盐 霜脲氰